Hypoxia-induced erythropoietin expression in human neuroblastoma requires a methylation free HIF-1 binding site

Journal of Cellular Biochemistry

Volumn 93, Issue 1, 2004, Pages 153-161

  Rössler, Jochen ^a,b   Stolze, Ineke ^a   Frede, Stilla ^a   Freitag, Patricia ^a   Schweigerer, Lothar ^a,c   Havers, Werner ^a   Fandrey, Joachim ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Erythropoietin; Hypoxia inducible factor 1; Neuroblastoma; Oxygen sensing; Tissue specific gene expression

Indexed keywords

ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 1; NEUROMODULIN; NEURON SPECIFIC ENOLASE; NEUROPEPTIDE Y; DNA BINDING PROTEIN; ERYTHROPOIETIN RECEPTOR; HELIX LOOP HELIX PROTEIN; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; BINDING SITE; CELL PROLIFERATION; CONTROLLED STUDY; ENHANCER REGION; GENE CONTROL; HUMAN; HUMAN CELL; HYPOXIA; METHYLATION; NEUROBLASTOMA; OXYGEN SENSING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANOXIA; CELL CULTURE; CELL DIFFERENTIATION; CPG ISLAND; DNA METHYLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PERIPHERAL NERVE TUMOR; WESTERN BLOTTING;

ANOXIA; BINDING SITES; BLOTTING, WESTERN; CELL DIFFERENTIATION; CPG ISLANDS; DNA METHYLATION; DNA-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIETIN; GENE EXPRESSION REGULATION; HELIX-LOOP-HELIX MOTIFS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEUROBLASTOMA; NUCLEAR PROTEINS; PERIPHERAL NERVOUS SYSTEM NEOPLASMS; RECEPTORS, ERYTHROPOIETIN; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 16644380412     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20133     Document Type: Article

References (30)

1. Acs G, Acs P, Beckwith SM, Pitts RL, Clements E, Wong K, Verma A. 2001. Erythropoietin and erythropoietin receptor expression in human cancer. Cancer Res 61:3561-3565.
2. Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M. 1990. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci USA 87:5978-5982.
3. Assandri R, Egger M, Gassmann M, Niggli E, Bauer C, Forster I, Gorlach A. 1999. Erythropoietin modulates intracellular calcium in a human neuroblastoma cell line. J Physiol (Lond) 516:343-352.
4. Berdel WE, Oberberg D, Reufi B, Thiel E. 1991. Studies on the role of recombinant human erythropoietin in the growth regulation of human nonhematopoietic tumor cells in vitro. Ann Hematol 63:5-8.
5. Berthold F. 1990. Overview: Biology of neuroblastoma. In: Pochedly C, editor. Neuroblastoma: Tumor biology and therapy. Boca Raton: CRC Press. pp 1-27.
6. Biedler JL, Helson L, Spengler BA. 1973. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33:2643-2652.
7. Campana WM, Misasi R, O'Brien JS. 1998. Identification of a neurotrophic sequence in erythropoietin. Int J Mol Med 1:235-241.
8. Carlini RG, Alonzo EJ, Dominguez J, Blanca I, Weisinger JR, Rothstein M, Bellorin-Font E. 1999. Effect of recombinant human erythropoietin on endothelial cell apoptosis. Kidney Int 55:546-553.
9. Dame C, Fahnenstich H, Freitag P, Hofmann D, Abdul-Nour T, Bartmann P, Fandrey J. 1998. Erythropoietin mRNA expression in human fetal and neonatal tissue. Blood 1992:3218-3225.
10. Dame C, Bartmann P, Wolber E, Fahnenstich H, Hofmann D, Fandrey J. 2000. Erythropoietin gene expression in different areas of the developing human central nervous system. Brain Res Dev Brain Res 125:69-74.
11. Ebert BL, Bunn HF. 1999. Regulation of the erythropoietin gene. Blood 1994:1864-1877.
12. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ, Ratcliffe PJ. 2001. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107:43-54.
13. Hughes M, Marsden HB, Palmer MK. 1974. Histologic patterns of neuroblastoma related to prognosis and clinical staging. Cancer 34:1706-1711.
14. Jelkmann W. 1992. Erythropoietin: Structure, control of production, and function. Physiol Rev 1972:449-489.
15. Juul SE, Anderson DK, Li Y, Christensen RD. 1998. Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr Res 43:40-49.
16. Komatsu N, Suda T, Moroi M, Tokuyama N, Sakata Y, Okada M, Nishida T, Hirai Y, Sato T, Fuse A. 1989. Growth and differentiation of a human megakaryoblastic cell line, CMK. Blood 74:42-48.
17. Masuda S, Nagao M, Takahata K, Konishi Y, Gallyas F, Jr., Tabira T, Sasaki R. 1993. Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells. J Biol Chem 268:11208-11216.
18. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ. 1999. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271-275.
19. Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R. 1997. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76:105-116.
20. Nordsmark M, Bentzen SM, Overgaard J. 1994. Measurement of human tumour oxygenation status by a polarographic needle electrode. An analysis of inter- and intratumour heterogeneity. Acta Oncol 33:383-389.
21. Ross RA, Spengler BA, Biedler JL. 1983. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Inst 71:741-747.
22. Rössler J, Breit S, Havers W, Schweigerer L. 1999. Vascular endothelial growth factor expression in human neuroblastoma: Up-regulation by hypoxia. Int J Cancer 81:113-117.
23. Rössler J, Schwab M, Havers W, Schweigerer L. 2001. Hypoxia promotes apoptosis in human neuroblastoma cell lines with enhanced Nmyc expression. BBRC 281:272-276.
24. Stolze I, Berchner-Pfannschmidt U, Freitag P, Wotzlaw C, Rössler J, Frede S, Acker H, Fandrey J. 2002. Hypoxia-inducible erythropoietin gene expression in human neuroblastoma cells. Blood 100:2623-2628.
25. Wanner RM, Spielmann P, Stroka DM, Camenisch G, Camenisch I, Scheid A, Houck DR, Bauer G, Gassmann M, Wenger RH. 2000. Epolones induce erythropoietin expression via hypoxia-inducible factor-1 alpha activation. Blood 96:1558-1565.
26. 2-regulated gene expression. FASEB J 16:1151-1162.
27. Wenger RH, Kvietikova I, Rolfs A, Camenisch G, Gassmann M. 1998. Oxygen-regulated erythropoietin gene expression is dependent on a CpG methylation-free hypoxia-inducible factor-1 DNA-binding site. Eur J Biochem 253:771-777.
28. Westenfelder C, Baranowski RL. 2000. Erythropoietin stimulates proliferation of human renal carcinoma cells. Kidney Int 58:647-657.
29. Wollman Y, Westphal G, Blum M, Simantov R, Blumberg S, Peer G, Chernihovsky T, Friedrich E, Iaina A. 1996. The effect of human recombinant erythropoietin on the growth of a human neuroblastoma cell line. Life Sci 59:315-322.
30. Youssoufian H, Longmore G, Neumann D, Yoshimura A, Lodish HF. 1993. Structure, function, and activation of the erythropoietin receptor. Blood 81:2223-2236.